Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5637320 | TWI PHARMS | Controlled absorption naproxen formulation for once-daily administration |
Jun, 2014
(9 years ago) |
Market Authorisation Date: 05 January, 1996
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10028925 | BIONPHARMA | Liquid dosage forms of sodium naproxen |
Mar, 2026
(1 year, 10 months from now) | |
US10022344 | BIONPHARMA | Liquid dosage forms of sodium naproxen |
Mar, 2026
(1 year, 10 months from now) | |
US9693979 | BIONPHARMA | Liquid dosage forms of sodium naproxen |
Mar, 2026
(1 year, 10 months from now) | |
US9693978 | BIONPHARMA | Solvent system for enhancing the solubility of pharmaceutical agents |
Mar, 2026
(1 year, 10 months from now) | |
US11090280 | BIONPHARMA | Liquid dosage forms of sodium naproxen |
Mar, 2026
(1 year, 10 months from now) |
Market Authorisation Date: 17 February, 2006
Treatment: Temporary reduction of fever
Dosage: CAPSULE;ORAL